Member Info for dustofnations

WongaFC, I agree, it seems ambitious, unless they are pretty close to re-signing and just needed to determine timelines before they could proceed. Guess we'll find out over the next couple of weeks.

When it comes to being ambitious on a technical level, they've always succeeded and exceeded expectations.

When it comes to being ambitious on a business dev timelines, it's rarely worked out as rapidly as they hoped. It certainly sounds like they have several opportunities near to taking the next big step, and hopefully the additional senior resources will help make that happen smoothly and rapidly.

The bioMSAR and MSAR products look very well-placed for the current market, regulatory, and economic conditions. Hopefully the easing of covid restrictions will let us start getting stuff into motion now.

As always with QFI - "let's see"; I'm sure we shall all be delighted if it happens sooner rather than later :-).

One of my biggest takeaways from this is that they are looking at bypassing static OEM testing entirely and going straight to vessel testing. We need to hear more on this ASAP, but this would be extremely good news if they can pull it off. We've speculated about what those possibilities might be, but obviously want to hear a concrete plan.

Note that they still hope to complete Morocco industrial trials within Q1, so let's hope we hear more on access plans and timetable imminently. Border restrictions are removed on 7th onwards, so should make it easier to start planning.

Quadrise Fuels bioMSAR Aquafuels testing results endorsement of potential

https://vimeo.com/672315898

I'm sure you all know, so apologies if this is saying the obvious, but the R&D arm of Quadrise is not the same people that do the commercial execution. So R&D folk working on this will not hinder/slow the commercial side of the business.

The R&D team have always exceeded expectations and done an absolutely wonderful job. Let us hope that the biz development people can finally hold up their side of the bargain by executing on the various trials and commercial opportunities.

It's a great RNS, the technical results are phenomenal and beyond what I expected they would manage. And remember, improved efficiency translates into better economics and lower CO2 emissions (i.e. using less fuel per distance sailed).

Let's hope we see the needed trials and other business development coming through promptly now that things are beginning to ease up with travel and other related restrictions/bottlenecks.

The goal of a zero-carbon bioMSAR skew has been mentioned during several talks (including the AGM), although not with that specific brand name. I like the name.

> It further aims to mix its oil with waste from bio-diesel to offset emissions and produce a bio-fuel.

Thanks for those links, foxm.

I presume that's the Quadrise bioMSAR link.

Waste from bio-diesel is mostly glycerol. bioMSAR uses glycerol mixed with heavy oil to produce their stable oil-in-water emulsion; this renewable glycerol displaces MSAR's traditional water element to match customer CO2 reduction requirements.

Isn't ETX Capital a CFD trading platform? ??

You have to wonder why they are investing in TomCo given their core business. Seems unusual.

See: https://www.moroccoworldnews.com/2022/01/346639/akhannouch-outlines-recommits-to-his-vision-after-first-100-days

"""
While noting that “there is a scientific committee and a ministerial committee that makes decisions that I am obliged to implement,” [Moroccan Prime Minister] Akhannouch expressed optimism about the reopening of the borders in the coming weeks.

He also appeared to put forth the government’s determination to revive Morocco’s tourism sector in the midst of far-reaching repercussions from the COVID crisis.
"""

Excellent presentation from Jeremy. There is plenty coming through in the POLB pipeline and it's well worth being patient in order to see some of these assets convert into deals.

Our agent in Morocco, Younes Maamar, is on the BoD for Chariot O&G Morocco -- https://find-and-update.company-information.service.gov.uk/company/11793685/officers

Thanks for the thoughts, Indigo.

ADR registration probably a tad too onerous in terms of regulatory overhead and cost at this point. I agree it is superior to OTC in terms of access and acceptance, of course.

A couple of companies I invest in on AIM are using OTC very successfully to improve liquidity and help improve investor diversity as they pivoted their strategy to be more US-centric (big market, after all, and they tend to value tech companies more in US).

OTC is very low cost and doesn't come with much administrative burden, which is handy. Certainly not as good as an ADR or dual listing, but it tends to do its job well. It's only $14,000-$23,000 pa depending which market you list on. I see

If we're going to be in Utah and Latin America, giving easier access to those investors would make sense, I believe.

Anyway, I popped it along to the team. Whether they have any interest is another matter! And, I'm sure they will want to have some movement on those key projects before it's worth investing in any kind of improved access for US investors.

As I forgot to say it previously: Happy New Year. Here's to hoping 2022 is a good one.

Yes, it can be annoyingly difficult for US investors to buy stocks outside of the country. The way their brokers and regulations work discourage Americans from investing outside of the country, except for ADR registered stocks.

One of the common workarounds is the OTC Markets; they basically provide a bridge that allows US investors to get involved. The problem is that the liquidity is much lower than using the real exchange directly.

If Quadrise want to get better exposure to US investors, they could upgrade to an official OTC listing (e.g. OTCQB). Another company I invest in did this recently quite successfully.

AIUI from the AGM, they believe the Panama project(s) could be relatively simple and perhaps be executed quite quickly given they are self-contained.

We've heard that before, though, so let's see how it goes.

It is good that they've got some trusted associates running that project for them in-country.

A key comment from Jason that could easily be missed.

As mentioned at the AGM, he remarked that OEMs are currently what is blocking progress on beginning the LONOs with bioMSAR and MSAR at MSC.

In this video he mentions that they have some ideas for how they could bypass the OEMS to get things going, and to 'watch this space' .

I hope that's sooner rather than later, because it's really frustrating for a third party OEM to be blocking a transformational project with the biggest shipping company in the world.

I listened to an interesting podcast today about immune system research, one part of which was discussing people's vulnerability to covid-19 via deficiencies in various innate immune functions, including interferon production and auto-antibodies to certain interferons. They concluded that IFN-Beta is a good candidate for supplementation/treatment because auto-antibodies to IFN-B is much less common, and hence is much more likely to trigger a good intracellular innate response (e.g. downregulation of certain cellular functions that viruses hijack).

To listen to the professor describing Prof Casanova's group's research on c19 and IFN, skip to approx: 19m:50s

https://www.science.org/content/podcast/why-trees-are-making-extra-nuts-year-human-genetics-and-viral-infections-and-seminal-book-racism-and-identity

Paper being discussed is: https://www.science.org/doi/10.1126/science.abj7965

I didn't say we have a sales director, no.

Board decides on MK replacement.

They decided to appoint Laurie Mutch as Interim Chairman until such time that they decide on an appropriate successor.

As we're at a transition period, it probably makes sense to have a different kind of chairman should we close out some of the deals that have been working on.

So, Laurie keeping the seat warm until that point makes sense to me.

I honestly don't think chairman is as important as COO and other operational, sales, and BD roles. And Laurie obviously has a very good reputation and is very knowledgable about the product (as those who have met him can attest). No issues from me.

https://vimeo.com/646943075

So, some exploratory drilling for the smallish downhole/in-situ should happen in the next few weeks.

Actual commercial-scale drilling and production realistically 1H2022 by the sounds of it.

So plausible that an MSAR deal will be signed in the near term, but I doubt any major use of our product will occur on-site until 2022 sometime. I personally wouldn't be surprised if we didn't get any signatures until 2022, and that doesn't worry me particularly. It's good for us that TOM + Valkor see MSAR as useful for both downhole/in-situ and sands opportunities.

As a reminder, they discovered that there is a modest resource that is deeper than the surface shale, but is relatively easily accessible and hence could generate useful revenues in fairly short order. The idea is that MSAR could be used for on-site energy requirements such as heat, steam, CO2 generation for enhanced recovery (EOR), and I guess to generate steam for SAGD in more extreme scenarios.

Oil with waste from biodiesel sounds like it could be bioMSAR (i.e. glycerol is the main waste product from biodiesel industry).

Yes, I posted this on the other forums. She made a wonderfully ambiguous statement of, "I must say, we have tried emulsion fuels before; but, more on that in the future".

Personally, I'm not going to get excited because it could mean many different things and Maersk don't have a great track record with MSAR. But, it's worth paying attention.

BTW, JM confirmed the possibility I speculated about in Quorumzine a few months ago that they believe they can use methanol as an additional feedstock.